Egypt - English - EDA (Egyptian Drug Authority)

elmeery for import & export & commercial agents - amprolium hcl 275 mg equivalent to amprolium base 250 mg/1 ml - oral solution

Egypt - English - EDA (Egyptian Drug Authority)

elmeery for import & export & commercial agents - amoxicillin trihydrate 11.48 gm (equivalent to 10gm amoxicillin base) colistin sulphate 4.75 gm (equivalent to 4gm colistin base)./100 gm - powder to be mixed with feed

Egypt - English - EDA (Egyptian Drug Authority)

elmeery for import & export & commercial agents - erythromycin thiocyanate 236 mg (eq. to erythromycin base 200 mg)/1gm - water soluble powder

Australia - English - Department of Health (Therapeutic Goods Administration)

tianda pharmaceuticals australia pty ltd - celery seed oil,juniper berry oil -

Australia - English - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - celery seed oil,juniper berry oil -

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - rivastigmine, quantity: 27 mg - drug delivery system, transdermal - excipient ingredients: acrylates copolymer; dl-alpha-tocopherol; dimeticone 12500; ethyl acetate; methylated trimethylated silica; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane - exelon / prometax is indicated for the treatment of patients with mild, moderate and severe dementia of the alzheimer's type.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - rivastigmine, quantity: 18 mg - drug delivery system, transdermal - excipient ingredients: dimeticone 12500; acrylates copolymer; dl-alpha-tocopherol; ethyl acetate; hexane; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; methylated trimethylated silica - exelon / prometax is indicated for the treatment of patients with mild, moderate and severe dementia of the alzheimer's type.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - rivastigmine, quantity: 9 mg - drug delivery system, transdermal - excipient ingredients: acrylates copolymer; dimeticone 12500; dl-alpha-tocopherol; ethyl acetate; hexane; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; methylated trimethylated silica - exelon / prometax is indicated for the treatment of patients with mild, moderate and severe dementia of the alzheimer's type.

Ireland - English - HPRA (Health Products Regulatory Authority)

laprovet - progesterone - vaginal delivery system - 1.55 gram(s) - progesterone - cattle - hormone

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - levonorgestrel, quantity: 52 mg - drug delivery system, intrauterine - excipient ingredients: dimethylsiloxane/methylvinylsiloxane cross linked elastomer - contraception. treatment of idiopathic menorrhagia. prevention of endometrial hyperplasia during oestrogen replacement therapy.